Respiratory syncytial virus infection in COVID-19 times: Trick or threat?

Affiliations

Editorial

Ana Isabel Menasalvas Ruiz. Enferm Infecc Microbiol Clin. 2023 Jun-Jul.

. 2023 Jun-Jul;41(6):319-320.

doi: 10.1016/j.eimc.2023.01.001. Epub 2023 Jan 12.

¹ Unidad de Infectología Pediátrica, Servicio de Pediatría, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.

No abstract available

Comment on

[Influence of the COVID-19 pandemic on the epidemiology of acute bronchiolitis].
Bermúdez Barrezueta L, Gutiérrez Zamorano M, López-Casillas P, Brezmes-Raposo M, Sanz Fernández I, Pino Vázquez MA. Bermúdez Barrezueta L, et al. Enferm Infecc Microbiol Clin. 2023 Jun-Jul;41(6):348-351. doi: 10.1016/j.eimc.2021.11.014. Epub 2021 Dec 22. Enferm Infecc Microbiol Clin. 2023. PMID: 34955579 Free PMC article. Spanish.
Respiratory syncytial virus outbreak during the COVID-19 pandemic. How has it changed?
Hernández-Rivas L, Pedraz T, Calvo C, San Juan I, Mellado MªJ, Robustillo A. Hernández-Rivas L, et al. Enferm Infecc Microbiol Clin. 2023 Jun-Jul;41(6):352-355. doi: 10.1016/j.eimc.2021.12.003. Epub 2021 Dec 22. Enferm Infecc Microbiol Clin. 2023. PMID: 34955580 Free PMC article.

1. Meissner H.C. Viral bronchiolitis in children. N Engl J Med. 2016;374:62–72. - PubMed
1. Li Y., Wang X., Blau D.M., Caballero M.T., Feikin D.R., Gill C.J., et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399:2047–2064. doi: 10.1016/S0140-6736(22)00478-0. - DOI - PMC - PubMed
1. Ghazaly M., Nadel S. Characteristics of children admitted to intensive care with acute bronchiolitis. Eur J Pediatr. 2018;177:913–920. doi: 10.1007/s00431-018-3138-6. - DOI - PMC - PubMed
1. Nam H.H., Ison M.G. Respiratory syncytial virus infection in adults. BMJ. 2019;366:l5021. doi: 10.1136/bmj.l5021. - DOI - PubMed
1. Buchwald A.G., Graham B.S., Traore A., Haidara F.C., Chen M., Morabito K., et al. Respiratory syncytial virus (RSV) neutralizing antibodies at birth predict protection from RSV illness in infants in the first 3 months of life. Clin Infect Dis. 2021;73:e4421–e4427. doi: 10.1093/cid/ciaa648. - DOI - PMC - PubMed